{"id":"e191a234-53d2-4518-80c5-1fcd453c5b28","name":"Edge Medical Robotics","slug":"edge-medical-robotics","description":"Shenzhen-based surgical robotics company developing world-leading single-port and multi-port surgical robots. Founded by Wang Jianchen, Edge Medical Robotics raised 2.6M in Series B funding from investors including HongShan, Temasek Holdings, and OrbiMed. The company achieved China's first single-port surgical robot approval for thoracic surgery and has secured over 2 billion yuan in total financing.","status":"active","founded":null,"hq":"Shenzhen, China","fundingTotal":"92600000","type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.edgerobotics.com","title":"edge-medical-robotics official website","sourceName":"edge-medical-robotics"}],"keyFacts":[{"label":"CEO","value":"Wang Jianchen"},{"label":"Series B","value":"2.6M"},{"label":"Investors","value":"HongShan, Temasek, OrbiMed"},{"label":"Products","value":"Single-port and multi-port surgical robots"}],"aliases":["Edge Medical"],"collisionRisk":"low","reviewNote":"wave=cn_robotics_netnew_w3; verified WebSearch; sub-segment=multi-port/single-port endoscopic surgical robots","atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-27T10:23:59.462Z","updatedAt":"2026-07-08T20:15:38.405Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/edge-medical-robotics","url":"https://registry.deploy.report/companies/edge-medical-robotics","name":"Edge Medical Robotics","alternateName":["Edge Medical"],"description":"Shenzhen-based surgical robotics company developing world-leading single-port and multi-port surgical robots. Founded by Wang Jianchen, Edge Medical Robotics raised 2.6M in Series B funding from investors including HongShan, Temasek Holdings, and OrbiMed. The company achieved China's first single-port surgical robot approval for thoracic surgery and has secured over 2 billion yuan in total financing.","identifier":"e191a234-53d2-4518-80c5-1fcd453c5b28","address":"Shenzhen, China","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}